IGC Pharma, Inc. IGC
$0.30
+1.29%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | FORM 10-Q | 2026-08-14 | View → |
| 8-K | FORM 8-K | 2026-07-14 | View → |
| 8-K | FORM 8-K | 2026-07-06 | View → |
| 4 | Insider transaction | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-07-01 | View → |
| 8-K | FORM 8-K | 2026-06-08 | View → |
| 10-Q | FORM 10-Q | 2026-05-15 | View → |
| 8-K | FORM 8-K | 2026-04-20 | View → |
| 4 | Insider transaction | 2026-04-06 | View → |
| 4 | Insider transaction | 2026-04-06 | View → |
| 4 | Insider transaction | 2026-04-06 | View → |
| 4 | Insider transaction | 2026-04-06 | View → |
| 8-K | FORM 8-K | 2026-03-30 | View → |
| 8-K | FORM 8-K | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 4 | Insider transaction | 2026-01-20 | View → |
| 8-K | FORM 8-K | 2026-01-06 | View → |
| 424B5 | FORM 424B5 | 2026-01-06 | View → |
| 8-K | FORM 8-K | 2026-01-02 | View → |
| 8-K | FORM 8-K | 2025-12-15 | View → |
| S-3 | FORM S-3 | 2025-11-17 | View → |
| 10-Q | FORM 10-Q | 2025-11-14 | View → |
| 8-K | FORM 8-K | 2025-11-14 | View → |
| 4 | Insider transaction | 2025-10-22 | View → |
| 4 | Insider transaction | 2025-10-21 | View → |
| 4 | Insider transaction | 2025-10-21 | View → |
| 4 | Insider transaction | 2025-10-21 | View → |
| 4 | Insider transaction | 2025-10-20 | View → |
| 8-K | FORM 8-K | 2025-10-14 | View → |
| 8-K | FORM 8-K | 2025-10-01 | View → |
| 424B5 | FORM 424B5 | 2025-09-19 | View → |
| DEF 14A | FORM DEF 14A | 2025-08-18 | View → |
| 10-Q | FORM 10-Q | 2025-08-14 | View → |
| S-3 | FORM S-3 | 2025-07-18 | View → |
| 10-K | FORM 10-K | 2025-06-27 | View → |
| 8-K | FORM 8-K | 2025-06-17 | View → |
| 10-Q | FORM 10-Q | 2025-02-14 | View → |
| 10-Q | FORM 10-Q | 2024-11-12 | View → |
| 4 | Insider transaction | 2024-09-27 | View → |
| 8-K | FORM 8-K | 2024-09-27 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $0.30
- Market Cap
- $29.84 million
- 52-Week Range
- $0.23 – $0.50
- Average Volume
- 599K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.